Biological therapies for the treatment of psoriasis in pediatrics

  • Published on 11/20/2023
  •  Reading time: 4 min.

Mariam Nikolaishvili a & Vito Di Lernia b

a Faculty of Medicine, Ivane Javakhishvili, Tbilisi State University, Tbilisi, Georgia
b Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

CONTACT Vito Di Lernia mailto:vito.dilernia@ausl.re.it Dermatology Unit, Arcispedale Santa Maria Nuova, viale Risorgimento 80, Reggio Emilia 42123, Italy

Abstract

Introduction Psoriasis is a multifactorial, immune-mediated condition with predominant skin involvement. It may develop at any age. In one-third of patients, the first symptoms of psoriasis start during childhood or adolescence. A marked impairment of the quality of life of patients and their caregivers is often associated.
Areas covered Databases including PubMed and Clinicaltrials.gov were used to identify clinical studies involving pediatric patients...

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Dermatology

Receive our newsletter to stay up to date with the latest news in Dermatology